A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines
Clinical trial NCT05933512 · UNKNOWN
Trial details
- NCT number
- NCT05933512
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2023-12-10
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.